Text Size

Secondary Prevention After Coronary Bypass Surgery

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Jeffrey Kramer, MD, University of Kansas Medical Center Research Institute
ClinicalTrials.gov Identifier:
NCT00843089
First received: February 12, 2009
Last updated: June 13, 2012
Last verified: June 2012
History of Changes
  Purpose

Despite immediate symptomatic success after coronary bypass surgery in patients with coronary artery disease, this effect is not sustained over time since risk factors for coronary artery disease are still in place. The role of secondary prevention becomes increasingly important as it can potentially decrease or eliminate the need for another intervention in these high risk subjects. This project seeks to evaluate the effect of emphasizing secondary prevention measures in this patient population during hospital admission and through six months post-discharge.


Condition Intervention
Coronary Artery Disease
 Other: Education

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Secondary Prevention After Coronary Bypass Surgery: A Pilot Study

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of Kansas:

Primary Outcome Measures:
  • compliance with medications and lifestyle changes [ Time Frame: Month 1, 3, 6 and 1 year ] [ Designated as safety issue: No ]

Estimated Enrollment: 100
Study Start Date: January 2009
Estimated Study Completion Date: January 2014
Estimated Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: 1
Standard care
Experimental: 2
Educational session with pharmacist, nutritionist, and cardiac rehabilitation nurse
 Other: Education
Educational session with pharmacist, nutritionist, and cardiac rehabilitation nurse

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Subjects over the age of 18 who will undergo a CABG procedure and who have given written informed consent

Exclusion Criteria:

  • Subjects under the age of 18 or who are unable to give consent on their own behald
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00843089

Locations
United States, Kansas
University of Kansas Medical Center
Kansas City, Kansas, United States, 66160
Sponsors and Collaborators
Jeffrey Kramer, MD
Investigators
Principal Investigator: Jeffrey Kramer, MD University of Kansas
  More Information

No publications provided

Responsible Party: Jeffrey Kramer, MD, CTS SURGEON, University of Kansas Medical Center Research Institute
ClinicalTrials.gov Identifier: NCT00843089     History of Changes
Other Study ID Numbers: 11562
Study First Received: February 12, 2009
Last Updated: June 13, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by University of Kansas:
coronary artery disease
CABG

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Diseases
 Cardiovascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on June 18, 2013